cimadronate has been researched along with tiludronic acid in 1 studies
| Studies (cimadronate) | Trials (cimadronate) | Recent Studies (post-2010) (cimadronate) | Studies (tiludronic acid) | Trials (tiludronic acid) | Recent Studies (post-2010) (tiludronic acid) |
|---|---|---|---|---|---|
| 105 | 3 | 4 | 123 | 28 | 23 |
| Protein | Taxonomy | cimadronate (IC50) | tiludronic acid (IC50) |
|---|---|---|---|
| 72 kDa type IV collagenase | Homo sapiens (human) | 7.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbier, A; Baron, R; David, P; Nguyen, H | 1 |
1 other study(ies) available for cimadronate and tiludronic acid
| Article | Year |
|---|---|
The bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H(+)-ATPase.
Topics: Alendronate; Animals; Binding, Competitive; Bone Resorption; Cell Membrane Permeability; Chickens; Diphosphonates; Dose-Response Relationship, Drug; Ethylmaleimide; Etidronic Acid; Female; Hydrogen-Ion Concentration; Kidney; Lethal Dose 50; Osteoclasts; Proton-Translocating ATPases; Saccharomyces cerevisiae; Synaptic Vesicles | 1996 |